Orphan designation: Dabrafenib mesylate, Treatment of glioma, 09/12/2020, Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 15 September 2023 - 11:00

Orphan designation: Dabrafenib mesylate, Treatment of glioma, 09/12/2020, Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-20-2372

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters